The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2

Andrea L Cathcart; Colin Havenar-Daughton; Florian A Lempp; Daphne Ma; Michael Schmid; Maria L Agostini; Barbara Guarino; Julia Di iulio; Laura Rosen; Heather Tucker; Joshua Dillen; Sambhavi Subramanian; Barbara Sloan; Siro Bianchi; Jason Wojcechowskyj; Jiayi Zhou; Hannah Kaiser; Arthur Chase; Elvin Lauron; Martin Montiel-Ruiz; Roberto Spreafico; Julia Noack; Nadine Czudnochowski; Anna Sahakyan; Dora Pinto; Christian Saliba; Katja Culap; Exequiel Delotta Jr.; Arnold Park; Elisabetta Cameroni; Sarah Ledoux; Yoshihiro Kawaoka; Adam Werts; Christophe Colas; Leah Soriaga; Amalio Telenti; Lisa A Purcell; Seungmin Hwang; Gyorgy Snell; Herbert W Virgin; Davide Corti; Christy M Hebner.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-434607